308 related articles for article (PubMed ID: 23268747)
1. Therapeutic targeting of cancer cell cycle using proteasome inhibitors.
Rastogi N; Mishra DP
Cell Div; 2012 Dec; 7(1):26. PubMed ID: 23268747
[TBL] [Abstract][Full Text] [Related]
2. Updated Review and Perspective on 20S Proteasome Inhibitors in the Treatment of Lung Cancer.
Rohondia SO; Ahmed ZSO; Dou QP
Curr Cancer Drug Targets; 2020; 20(6):392-409. PubMed ID: 32101123
[TBL] [Abstract][Full Text] [Related]
3. Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes.
Ignatz-Hoover JJ; Murphy EV; Driscoll JJ
Front Cell Infect Microbiol; 2022; 12():925804. PubMed ID: 35873166
[TBL] [Abstract][Full Text] [Related]
4. Toward understanding induction of oxidative stress and apoptosis by proteasome inhibitors.
Paniagua Soriano G; De Bruin G; Overkleeft HS; Florea BI
Antioxid Redox Signal; 2014 Dec; 21(17):2419-43. PubMed ID: 24437477
[TBL] [Abstract][Full Text] [Related]
5. Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes.
Grover A; Shandilya A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S15. PubMed ID: 21143798
[TBL] [Abstract][Full Text] [Related]
6. The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.
Piccinini M; Rinaudo MT; Anselmino A; Buccinnà B; Ramondetti C; Dematteis A; Ricotti E; Palmisano L; Mostert M; Tovo PA
Antivir Ther; 2005; 10(2):215-23. PubMed ID: 15865215
[TBL] [Abstract][Full Text] [Related]
7. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
[TBL] [Abstract][Full Text] [Related]
8. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
Staszczak M
Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance.
Narayanan S; Cai CY; Assaraf YG; Guo HQ; Cui Q; Wei L; Huang JJ; Ashby CR; Chen ZS
Drug Resist Updat; 2020 Jan; 48():100663. PubMed ID: 31785545
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and the proteasome.
Grimm LM; Osborne BA
Results Probl Cell Differ; 1999; 23():209-28. PubMed ID: 9950035
[TBL] [Abstract][Full Text] [Related]
11. Targeting the ubiquitin-proteasome pathway: an emerging concept in cancer therapy.
Frezza M; Schmitt S; Dou QP
Curr Top Med Chem; 2011 Dec; 11(23):2888-905. PubMed ID: 21824109
[TBL] [Abstract][Full Text] [Related]
12. The vital link between the ubiquitin-proteasome pathway and DNA repair: impact on cancer therapy.
Motegi A; Murakawa Y; Takeda S
Cancer Lett; 2009 Sep; 283(1):1-9. PubMed ID: 19201084
[TBL] [Abstract][Full Text] [Related]
13. NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.
Waku T; Nakamura N; Koji M; Watanabe H; Katoh H; Tatsumi C; Tamura N; Hatanaka A; Hirose S; Katayama H; Tani M; Kubo Y; Hamazaki J; Hamakubo T; Watanabe A; Murata S; Kobayashi A
Mol Cell Biol; 2020 Apr; 40(10):. PubMed ID: 32123008
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
Abaza MS; Bahman AM; Al-Attiyah RJ; Kollamparambil AM
Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
[TBL] [Abstract][Full Text] [Related]
15. The proteasome, a new target for cancer therapy.
Gillessen S; Groettup M; Cerny T
Onkologie; 2002 Dec; 25(6):534-9. PubMed ID: 12566898
[TBL] [Abstract][Full Text] [Related]
16. Induction of G1 arrest and apoptosis in human jurkat T cells by pentagalloylglucose through inhibiting proteasome activity and elevating p27Kip1, p21Cip1/WAF1, and Bax proteins.
Chen WJ; Lin JK
J Biol Chem; 2004 Apr; 279(14):13496-505. PubMed ID: 14726525
[TBL] [Abstract][Full Text] [Related]
17. Proteasomes are a target of the anti-tumour drug vinblastine.
Piccinini M; Tazartes O; Mezzatesta C; Ricotti E; Bedino S; Grosso F; Dianzani U; Tovo PA; Mostert M; Musso A; Rinaudo MT
Biochem J; 2001 Jun; 356(Pt 3):835-41. PubMed ID: 11389692
[TBL] [Abstract][Full Text] [Related]
18. Measuring the Overall Rate of Protein Breakdown in Cells and the Contributions of the Ubiquitin-Proteasome and Autophagy-Lysosomal Pathways.
Sha Z; Zhao J; Goldberg AL
Methods Mol Biol; 2018; 1844():261-276. PubMed ID: 30242715
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin-proteasome system as a prospective molecular target for cancer treatment and prevention.
Chen D; Dou QP
Curr Protein Pept Sci; 2010 Sep; 11(6):459-70. PubMed ID: 20491623
[TBL] [Abstract][Full Text] [Related]
20. The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic Options.
Di Costanzo A; Del Gaudio N; Conte L; Altucci L
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
